Page last updated: 2024-11-07

methylprednisolone acetate and Rupture

methylprednisolone acetate has been researched along with Rupture in 2 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Rupture: Forcible or traumatic tear or break of an organ or other soft part of the body.

Research Excerpts

ExcerptRelevanceReference
"Fifty-six cases of De Quervain's tenosynovitis (in 55 patients) were treated with a "long-acting" corticosteroid, methylprednisolone acetate, and followed prospectively over a 4-year period."3.68Treatment of De Quervain's tenosynovitis with corticosteroids. A prospective study of the response to local injection. ( Anderson, BC; Brouns, MC; Manthey, R, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maman, E1
Yehuda, C1
Pritsch, T1
Morag, G1
Brosh, T1
Sharfman, Z1
Dolkart, O1
Anderson, BC1
Manthey, R1
Brouns, MC1

Other Studies

2 other studies available for methylprednisolone acetate and Rupture

ArticleYear
Detrimental Effect of Repeated and Single Subacromial Corticosteroid Injections on the Intact and Injured Rotator Cuff: A Biomechanical and Imaging Study in Rats.
    The American journal of sports medicine, 2016, Volume: 44, Issue:1

    Topics: Adrenal Cortex Hormones; Animals; Biomechanical Phenomena; Bone Density; Humans; Injections, Intra-A

2016
Treatment of De Quervain's tenosynovitis with corticosteroids. A prospective study of the response to local injection.
    Arthritis and rheumatism, 1991, Volume: 34, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Delayed-Action Preparations; Drug Evaluati

1991